Saint Sebastien/Loire, France

Guillaume Lebaut


Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 71(Granted Patents)


Location History:

  • Saint-Sebastien, FR (1999)
  • Saint Sebastien/Loire, FR (1999 - 2005)

Company Filing History:


Years Active: 1999-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Guillaume Lebaut

Introduction

Guillaume Lebaut is a notable inventor based in Saint Sebastien/Loire, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on N-substituted indole-3-glyoxylamides. With a total of four patents to his name, Lebaut's inventions focus on addressing critical health issues such as asthma and allergies.

Latest Patents

Lebaut's latest patents include novel N-substituted indole-3-glyoxylamides that exhibit anti-asthmatic, antiallergic, and immunosuppressant/immunomodulating actions. These compounds are not only groundbreaking in their formulation but also in their potential pharmaceutical applications. The processes for their preparation and their therapeutic uses highlight the importance of his research in improving patient care.

Career Highlights

Throughout his career, Guillaume Lebaut has worked with prominent companies in the pharmaceutical industry, including Asta Medica and Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.

Collaborations

Lebaut has collaborated with esteemed colleagues such as Bernhard Kutscher and Peter Emig. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Guillaume Lebaut's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…